{"id":"https://openalex.org/W2182194348","doi":null,"title":"Tapentadol and Dual Pain Inhibition: A New Strategy for Pain Relief in Australia","display_name":"Tapentadol and Dual Pain Inhibition: A New Strategy for Pain Relief in Australia","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2182194348","mag":"2182194348"},"language":"en","primary_location":{"id":"pmh:oai:pure.atira.dk:publications/8cdd835b-cfeb-49c4-9dfe-b77d7db1ed3b","doi":null,"is_oa":false,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/8cdd835b-cfeb-49c4-9dfe-b77d7db1ed3b","pdf_url":null,"source":{"id":"https://openalex.org/S4306402523","display_name":"UWA Profiles and Research Repository (University of Western Australia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pergolizzi, JD, Schug, S, Raffa, RB & Taylor, R 2015, 'Tapentadol and Dual Pain Inhibition: A New Strategy for Pain Relief in Australia', International Journal of Chronic Diseases, pp. 1011-1018.","raw_type":"info:eu-repo/semantics/review"},"volume":null,"type":"review","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040109608","display_name":"Joseph V. Pergolizzi","orcid":"https://orcid.org/0000-0001-5658-1471","observed_orcids":["https://orcid.org/0000-0001-5658-1471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.V. Pergolizzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050116562","display_name":"Stephan Alexander Schug","orcid":"https://orcid.org/0000-0002-0302-2315","observed_orcids":["https://orcid.org/0000-0002-0302-2315"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Stephan A. Schug","raw_affiliation_strings":["UWA Medical School"],"raw_orcid":"https://orcid.org/0000-0002-0302-2315","affiliations":[{"raw_affiliation_string":"UWA Medical School","institution_ids":["https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077593052","display_name":"Robert B. Raffa","orcid":"https://orcid.org/0000-0002-1456-4451","observed_orcids":["https://orcid.org/0000-0002-1456-4451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RB Raffa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056052291","display_name":"Robert Taylor","orcid":"https://orcid.org/0000-0001-5971-361X","observed_orcids":["https://orcid.org/0000-0001-5971-361X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Taylor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0616,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.08249158,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"1011","last_page":"1018"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.6503999829292297,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.6503999829292297,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.32420000433921814,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10189","display_name":"Anesthesia and Pain Management","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tapentadol","display_name":"tapentadol","score":1.0},{"id":"https://openalex.org/keywords/dual-mechanism-of-action","display_name":"dual mechanism of action","score":0.8270000219345093},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.8199999928474426},{"id":"https://openalex.org/keywords/noradrenaline-reuptake-inhibition","display_name":"norepinephrine reuptake inhibition","score":0.9850000143051147},{"id":"https://openalex.org/keywords/endogenous-opioids","display_name":"endogenous opioids","score":0.6570000052452087},{"id":"https://openalex.org/keywords/monoaminergic-systems","display_name":"monoaminergic systems","score":0.625},{"id":"https://openalex.org/keywords/descending-pain-modulation","display_name":"descending pain modulation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/analgesic-combination-therapy","display_name":"analgesic combination therapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8550000190734863},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/pain-management","display_name":"pain management","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2780505013","wikidata":"https://www.wikidata.org/wiki/Q414463","display_name":"Tapentadol","level":4,"score":0.6743497848510742},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5736560225486755},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.5288760662078857},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.49261265993118286},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4393559396266937},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4287336468696594},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4265945255756378},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3824290335178375},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.23889842629432678},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20241224765777588},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1309431791305542},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:pure.atira.dk:publications/8cdd835b-cfeb-49c4-9dfe-b77d7db1ed3b","doi":null,"is_oa":false,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/8cdd835b-cfeb-49c4-9dfe-b77d7db1ed3b","pdf_url":null,"source":{"id":"https://openalex.org/S4306402523","display_name":"UWA Profiles and Research Repository (University of Western Australia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pergolizzi, JD, Schug, S, Raffa, RB & Taylor, R 2015, 'Tapentadol and Dual Pain Inhibition: A New Strategy for Pain Relief in Australia', International Journal of Chronic Diseases, pp. 1011-1018.","raw_type":"info:eu-repo/semantics/review"},{"id":"mag:2182194348","doi":null,"is_oa":false,"landing_page_url":"https://austinpublishinggroup.com/chronic-diseases/download.php?file=fulltext/chronicdiseases-v2-id1011.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210207744","display_name":"International Journal of Chronic Diseases","issn_l":"2314-5749","issn":["2314-5749","2356-6981"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Chronic Diseases","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W89558675","https://openalex.org/W396364033","https://openalex.org/W1524044784","https://openalex.org/W1531562561","https://openalex.org/W1531652678","https://openalex.org/W1562338169","https://openalex.org/W1564287406","https://openalex.org/W1575329597","https://openalex.org/W1910554438","https://openalex.org/W1930905355","https://openalex.org/W1960545086","https://openalex.org/W1964846979","https://openalex.org/W1965614726","https://openalex.org/W1980190867","https://openalex.org/W2003069609","https://openalex.org/W2003872067","https://openalex.org/W2005284257","https://openalex.org/W2016122617","https://openalex.org/W2028140282","https://openalex.org/W2029803702","https://openalex.org/W2032341807","https://openalex.org/W2045707303","https://openalex.org/W2072036446","https://openalex.org/W2072565850","https://openalex.org/W2079718824","https://openalex.org/W2087628574","https://openalex.org/W2089633836","https://openalex.org/W2092782520","https://openalex.org/W2094310013","https://openalex.org/W2100480651","https://openalex.org/W2105991832","https://openalex.org/W2107450474","https://openalex.org/W2108129761","https://openalex.org/W2138106505","https://openalex.org/W2151304272","https://openalex.org/W2151526024","https://openalex.org/W2152359315","https://openalex.org/W2157999436","https://openalex.org/W2167931192","https://openalex.org/W2170823871","https://openalex.org/W2280029379","https://openalex.org/W2297721326","https://openalex.org/W2327925550","https://openalex.org/W2329656094","https://openalex.org/W2568896786"],"related_works":["https://openalex.org/W4410628158","https://openalex.org/W71057974","https://openalex.org/W2113642820","https://openalex.org/W2061071033","https://openalex.org/W2103191526","https://openalex.org/W2793525186","https://openalex.org/W2156173888","https://openalex.org/W1810661410","https://openalex.org/W4300012268","https://openalex.org/W2158412039"],"abstract_inverted_index":{"Although":[0],"prevalent,":[1],"pain":[2,9,53,69,146,192],"is":[3,161],"often":[4],"under-treated,":[5],"in":[6,67,98,142,204,214],"part":[7],"because":[8],"can":[10,95,109],"involve":[11],"multiple":[12,55,106],"physiological":[13],"mechanisms.":[14],"Pain":[15],"signals":[16],"are":[17,23,30,135,141,147,158],"transmitted":[18],"via":[19,25],"ascending":[20],"pathways":[21,29],"and":[22,38,45,83,118,137,176,201,206,221,232],"modulated":[24],"descending":[26],"pathways.":[27],"The":[28,125,194],"influenced":[31],"by":[32],"a":[33,61,73,120,162,168],"complex":[34],"interplay":[35],"of":[36,76,81,93,115,127,171,182,197,226,229],"inhibitory":[37],"excitatory":[39],"actions":[40],"involving":[41],"the":[42,113,179,215,223,236],"endogenous":[43],"opioid":[44],"mono":[46],"aminergic":[47],"(e.g.":[48],"nor":[49],"adrenaline)":[50],"systems.":[51],"When":[52],"involves":[54],"mechanisms,":[56],"analgesics":[57,157],"that":[58,166],"inhibit":[59],"only":[60],"single":[62],"system":[63],"will":[64],"likely":[65],"result":[66],"suboptimal":[68],"relief,":[70],"possibly":[71],"initiating":[72],"vicious":[74],"cycle":[75],"escalating":[77],"doses,":[78],"accelerated":[79],"onset":[80],"dependence/tolerance,":[82],"excess":[84],"side":[85],"effects.":[86],"Combining":[87],"two":[88],"agents":[89],"with":[90,211],"complementary":[91],"mechanisms":[92],"action":[94,198],"be":[96,110],"effective":[97],"treating":[99],"such":[100],"multi":[101,190],"mechanistic":[102,191],"pain,":[103],"but":[104,209],"taking":[105,149],"individual":[107],"drugs":[108,134],"inconvenient":[111],"to":[112,144,219,235],"point":[114],"compromising":[116],"compliance,":[117],"presaging":[119],"potentially":[121],"dangerous":[122],"poly":[123],"pharmacy.":[124],"risk":[126],"drug-drug":[128],"interactions":[129],"increases":[130],"dramatically":[131],"as":[132],"more":[133],"added,":[136],"many":[138],"patients":[139],"who":[140],"moderate":[143],"severe":[145],"already":[148],"several":[150],"other":[151],"prescriptions":[152],"for":[153,189],"underlying":[154],"disorders":[155],"before":[156],"added.":[159],"Tapentadol":[160],"new":[163],"analgesic":[164],"agent":[165],"has":[167],"dual":[169,195],"mechanism":[170,196],"action-it":[172],"activates":[173],"\u00b5-opioid":[174],"receptors":[175],"also":[177],"inhibits":[178],"neuronal":[180],"reuptake":[181],"norepinephrine,":[183],"making":[184],"it":[185],"an":[186],"attractive":[187],"match":[188],"syndromes.":[193],"was":[199],"designed":[200],"observed":[202],"using":[203],"vitro":[205],"animal":[207],"testing,":[208],"now":[210],"3":[212],"years":[213],"clinic,":[216],"we":[217],"aim":[218],"present":[220],"evaluate":[222],"successful":[224],"\u201ctranslation\u201d":[225],"these":[227],"types":[228],"design":[230],"strategies":[231],"preclinical":[233],"data":[234],"Australian":[237],"clinic.":[238]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}